4-Methoxycinnamic Acid Ethyl Ester is an derivative of 4-Methoxycinnamic Acid (M262150), an antihyperglycemic/hypoglycemic agent that works by stimulating insulin secretion from pancreas and could be developed into a new potential for therapeutic agent used in type 2 diabetic patients.
